4 Investigational Weight Loss Drugs That Could Change the Market

4 Investigational Weight Loss Drugs That Could Change the Market

Source: 
BioSpace
snippet: 

Weight-loss treatments have quickly emerged as one of the hottest areas for R&D in the pharmaceutical industry. The rapidly realized blockbuster sales of the leading drugs in the space, Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound, means there is a strong interest in the pipeline of follow-on and next-generation drugs.